Use the labels in the right column to find what you want. Or you can go thru them one by one, there are only 33,991 posts. Searching is done in the search box in upper left corner. I blog on anything to do with stroke. DO NOT DO ANYTHING SUGGESTED HERE AS I AM NOT MEDICALLY TRAINED, YOUR DOCTOR IS, LISTEN TO THEM. BUT I BET THEY DON'T KNOW HOW TO GET YOU 100% RECOVERED. I DON'T EITHER BUT HAVE PLENTY OF QUESTIONS FOR YOUR DOCTOR TO ANSWER.
Changing stroke rehab and research worldwide now.Time is Brain!trillions and trillions of neuronsthatDIEeach day because there areNOeffective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.
What this blog is for:
My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.
This is the whole problem in stroke enumerated in one word; 'care'; NOT RECOVERY!
YOU have to get involved and change this failure mindset of 'care' to 100% RECOVERY! Survivors want RECOVERY, NOT 'CARE'!
ASK SURVIVORS WHAT THEY WANT, THEY'LL NEVER RESPOND 'CARE'! This tyranny of low expectations has to be completely rooted out of any stroke conversation!
The evidence-based acute treatment of stroke patients in Germany is carried out according to standardized algorithms in more than 300 certified stroke units, and its quality is repeatedly assured by the German Stroke Society (DSG) and others. However, nationally structured and uniform stroke aftercare programs are missing, despite evidence that they contribute to the success of rehabilitation and improvement of everyday life. We used a 27-item online questionnaire, which was mailed to 4,195 outpatient physicians in the catchment area of the neurovascular network Neurovascular Network North Rhine plus (NEVANO+) located in the western part of Germany to assess actual structures of stroke aftercare, identify barriers, and possible solutions. Based on 152 completed anonymous answers to the questionnaire, a descriptive evaluation revealed that general practitioners and neurologists are seen to be responsible for stroke aftercare. Important improvement aspects, among others, were identified in intersectoral cooperation, the use of a post-stroke checklist, and connections to local self-help organizations. Stroke units could play a key role in stroke aftercare by providing these checklists, connecting self-help organizations, and offering education and coaching for supportive coordinating staff. Furthermore, existing neurovascular networks can be expanded to include rehabilitation clinics, geriatric clinics, and outpatient physicians to improve intersectoral communication, collaboration, and post-stroke care. Further studies should investigate whether intersectoral cooperation, checklists, and cooperation with self-help organizations within an extended neurovascular network have a positive impact on stroke aftercare and patients’ quality of life.
Comprehensive
stroke centers (CSC) offer state-of-the-art stroke care in metropolitan
centers. However, in rural areas sufficient stroke expertise is much
scarcer. Recently, telemedical stroke networks have offered instant
consultation by stroke experts, enabling immediate administration of
intravenous thrombolysis (IVT) on-site and decision on thrombectomy.
While these immediate decisions are made during the consult, the impact
of the network structures on stroke care in spoke hospitals is still not
well described.
Aims.
This
study was performed to determine if on-site performance in rural
hospitals and patient outcome improve over time through participation
and regular medical staff training within a telemedical stroke network.
Methods.
In
this retrospective study, we analyzed data from stroke patients treated
in four regional hospitals within the telemedical Neurovascular Network
of Southwest Bavaria (NEVAS) between 2014-2019. We only included those
patients that were treated in the regional hospitals until discharge at
home or to neurorehabilitation. Functional outcome (modified Rankin
scale) at discharge, mortality rate and periprocedural intracranial
hemorrhage served as primary outcome parameters. Door-to-imaging and
door-to-needle times were secondary outcome parameters.
Results.
In
2014-2019, 5,379 patients were treated for acute stroke with 477
receiving IVT. Most baseline characteristics were comparable over time.
For all stroke patients, door-to-imaging times increased over the years,
but significantly improved for potential IVT candidates and those
finally treated with IVT. The percentage of patients with door-to-needle
time <30 minutes increased from 10% to 25%. Clinical outcome at
discharge improved for all stroke patients treated in the regional
hospitals. Particularly for patients treated with IVT, good clinical
outcome (modified Rankin scale 0-2) at discharge increased from 2014 to
2019 by 19% and mortality rates dropped from 13% to 5%.
Conclusions.
24h/7d
telemedical support and regular on-site medical staff training within a
structured telemedicine stroke network such as NEVAS significantly
improve on-site stroke care(You need to measure results!)in rural areas, leading to a considerable
benefit in clinical outcome. Data access statement: The data that
support the findings of this study are available upon reasonable request
and in compliance with the local and international ethical guidelines.
Comprehensive
stroke centers (CSC) offer state-of-the-art stroke care in metropolitan
centers. However, in rural areas sufficient stroke expertise is much
scarcer. Recently, telemedical stroke networks have offered instant
consultation by stroke experts, enabling immediate administration of
intravenous thrombolysis (IVT) on-site and decision on thrombectomy.
While these immediate decisions are made during the consult, the impact
of the network structures on stroke care in spoke hospitals is still not
well described.
Aims.
This
study was performed to determine if on-site performance in rural
hospitals and patient outcome improve over time through participation
and regular medical staff training within a telemedical stroke network.
Methods.
In
this retrospective study, we analyzed data from stroke patients treated
in four regional hospitals within the telemedical Neurovascular Network
of Southwest Bavaria (NEVAS) between 2014-2019. We only included those
patients that were treated in the regional hospitals until discharge at
home or to neurorehabilitation. Functional outcome (modified Rankin
scale) at discharge, mortality rate and periprocedural intracranial
hemorrhage served as primary outcome parameters. Door-to-imaging and
door-to-needle times were secondary outcome parameters.
Results.
In
2014-2019, 5,379 patients were treated for acute stroke with 477
receiving IVT. Most baseline characteristics were comparable over time.
For all stroke patients, door-to-imaging times increased over the years,
but significantly improved for potential IVT candidates and those
finally treated with IVT. The percentage of patients with door-to-needle
time <30 minutes increased from 10% to 25%. Clinical outcome at
discharge improved for all stroke patients treated in the regional
hospitals. Particularly for patients treated with IVT, good clinical
outcome (modified Rankin scale 0-2) at discharge increased from 2014 to
2019 by 19% and mortality rates dropped from 13% to 5%.
Conclusions.
24h/7d
telemedical support and regular on-site medical staff training within a
structured telemedicine stroke network such as NEVAS significantly
improve on-site stroke care(You need to measure results!) in rural areas, leading to a considerable
benefit in clinical outcome. Data access statement: The data that
support the findings of this study are available upon reasonable request
and in compliance with the local and international ethical guidelines.
In an analysis of acute stroke hospitalizations in Germany, women had
greater risk for in-hospital mortality than men despite having fewer
complications, researchers reported at the International Stroke
Conference.
Dearbhla M. Kelly
Dearbhla M. Kelly, MD, DPhil,
nephrologist and stroke research fellow at Massachusetts General
Hospital, and colleagues analyzed 1,882,930 patients (48% women)
hospitalized for acute stroke in Germany from 2014 to 2019.
Data were derived from Kelly DM, et al. LB14. Presented at:
International Stroke Conference; Feb. 9-11, 2022; New Orleans (hybrid
meeting).
“There has been a lot of heterogeneity in the literature to date ...
and previous studies may have lacked a certain national
representativeness, and there may have been some selection bias,” Kelly
said during a presentation. “There are also some knowledge gaps for
recent temporal trends.”
Women tend to be older than men at presentation (ischemic stroke: median age, 79 years vs. 73 years; P < .001; hemorrhagic stroke: median age, 76 years vs. 74 years; P
< .001). Admission rates declined from 2017 to 2019, particularly
for ischemic stroke in women, Kelly said, noting that admission rates
were higher for men throughout the study period.
Among the ischemic stroke cohort,
women were more likely than men to have hypertension, atrial
fibrillation, chronic HF, chronic kidney disease and dementia, whereas
men were more likely than women to have cancer, CHD and diabetes and to
be current smokers (P < .001 for all), Kelly said during the presentation.
In the hemorrhagic stroke cohort,
almost all risk factors were more common in men vs. women, including
hypertension, cancer, chronic kidney disease and diabetes (P < .001 for all), she said.
In patients with ischemic stroke, men were more likely than women to have carotid interventions (endarterectomy, 2.3% vs. 1.1%; P < .001; stenting, 1.4% vs. 0.7%; P < .001), but women were more likely than men to receive thrombectomy (3.6% vs. 4.5%; P < .001), and there was no difference by sex in use of thrombolysis, she said.
“These differences may reflect differences in the underlying
pathology as opposed to differences in the care received,” Kelly said.
Compared with women with ischemic stroke, men experienced higher
rates of complications such as acute kidney injury, sepsis, need for
mechanical ventilation, as well as longer length of stay and higher
costs (P <. 001 for all), but women had higher rates of in-hospital mortality (5.5% vs. 8.1%; P < .001), according to the researchers.
Among patients with hemorrhagic stroke, there was no difference by
sex in craniectomy and evacuation of intracranial hemorrhage, but men
had greater rates of acute kidney injury, sepsis and need for dialysis (P < .001), and women had greater rates of bleeding (P < .001) and in-hospital mortality (16% vs. 20%; P < .001), Kelly said.
The unadjusted ORs for in-hospital mortality in women compared with
men were 1.43 (95% CI, 1.42-1.45) for total stroke, 1.52 (95% CI,
1.5-1.54) for ischemic stroke and 1.32 (95% CI, 1.29-1.34) for
hemorrhagic stroke, Kelly said during the presentation.
In a multivariate logistic regression analysis, female sex was an
independent predictor of in-hospital mortality for patients with any
stroke (adjusted OR = 1.16; 95% CI, 1.15-1.17; P < .001), ischemic stroke (aOR = 1.12; 95% CI, 1.11-1.14; P < .001) and hemorrhagic stroke (aOR = 1.19; 95% CI, 1.16-1.21; P < .001), according to the researchers.
“This may be attributable to the increased age of female patients,
their tendency toward more severe stroke, greater burden of atrial
fibrillation and pre-stroke functional limitations and disabilities,”
Kelly said during the presentation. “It has also been proposed that
there may be sex-specific functional cerebral asymmetries that underlie
differences in stroke severity between the sexes. We know there is a
lack of therapeutic options for [intracerebral hemorrhage] and a high
complication rate in general.”
This just shows you how fucking bad stroke is.THEY ARE NOT EVEN MEASURING 100% RECOVERY. No measurements, no possibility of getting better rehab. If you don't know what is wrong you can't fix it.
Data
on long-term survival and recurrence after stroke are lacking. We
investigated time trends in ischemic stroke case-fatality and recurrence
rates over 20-years stratified by etiological subtype according to the
Trial of ORG 10172 in Acute Stroke Treatment classification within a
population-based stroke register in Germany.
Methods:
Data
was collected within the Erlangen Stroke Project, a prospective,
population-based stroke register covering a source population of 105 164
inhabitants (2010). Case fatality and recurrence rates for 3 months, 1
year, and 5 years were estimated with Kaplan-Meier estimates.
Sex-specific time trends for case-fatality and recurrence rates were
estimated with Cox regression. We adjusted for age, sex, and year of
event and stratified for etiological subtypes. A sensitivity analysis
with competing risk analysis for time trends in recurrence were
performed.
Results:
Between
1996 and 2015, 3346 patients with first ischemic stroke were included;
age-standardized incidence per 100 000 was 75.8 in women and 131.6 in
men (2015). Overall, 5-year survival probabilities were 50.4% (95% CI,
47.9–53.1) in women and 59.2% (95% CI, 56.4–62.0) in men; 5-year
survival was highest in patients with first stroke due to small-artery
occlusion (women, 71.8% [95% CI, 67.1–76.9]; men, 75.9% [95% CI,
71.3–80.9]) and lowest in cardioembolic stroke (women, 35.7% [95% CI,
31.0–41.1]; men, 47.8% [95% CI, 42.2–54.3]). Five-year recurrence rates
were 20.1% (95% CI, 17.5–22.6) in women and 20.1% (95% CI, 17.5–22.7) in
men; 5-year recurrence rate was lowest in women in stroke due to small
artery occlusion 16.0% (95% CI, 11.7–20.1) and in men in large-artery
atherosclerosis 16.6% (95% CI, 8.7–23.9); highest risk of recurrence was
observed in undefined strokes (women, 22.3% [95% CI, 17.8–26.6]; men,
21.4% [95% CI, 16.7–25.9]). Cox regression revealed improvements in
case-fatality rates over time with differences in stroke causes. No time
trends in recurrence rates were observed.
Conclusions:
Long-term
survival and recurrence varied substantially by first stroke cause.
Survival probabilities improved over the past 2 decades; no major trends
in stroke recurrence rates were observed.
Footnotes
Presented in part as an oral presentation at the European Stroke Organisation Conference, Milano, 22–24 May 2019.
For Sources of Funding and Disclosures, see page 2784.
Correspondence
to: Peter L. Kolominsky-Rabas, MD, PhD, MBA, Erlangen Stroke Project,
Interdisciplinary Centre for Health Technology Assessment (HTA) and
Public Health, Friedrich-Alexander-University of Erlangen-Nürnberg,
Germany, Schwabachanlage 6, 91052 Erlangen, Bavaria, Germany. Email peter.kolominsky@uk-erlangen.de
From this you can see that there is nothing standardized about bringing in stroke interventions. You're screwed until that changes. It will never change until those with the most skin in the game are in charge(stroke survivors). And the first thing you can see from this is that they aren't even doing protocols, just lazy guidelines.
People with stroke cite mobility deficits
as one of the most burdensome limitations. National and international
stroke guidelines recommend physical therapy based on task-oriented
practice, with high numbers of repetitions(EXACT NUMBER NEEDED as a protocol would specify) to improve mobility. In the
outpatient setting in Germany and Austria, these principles have not yet
been established. The purpose of this study was to identify an
evidence-based intervention that could help reduce this
research-practice gap.
A stepwise approach proposed by
Voigt-Radloff et al and Cochrane Germany was used. First, the specific
health service problem in the German and Austrian physical therapy
outpatient context was identified. Second, a promising intervention was
identified using a systematic search in the Cochrane Library and grading
the quality of the evidence using GRADE. Finally, the transferability
of the promising intervention into the local context was evaluated using
predefined questions from the Cochrane guide and reports from health
insurances, professional organizations, and national stroke guidelines.
Task-oriented
circuit training reviewed by English et al was chosen. The review
showed clinically important improvements in walking distance and speed.
The quality of the evidence was graded high for these 2 outcomes. We
identified contextual challenges for implementation at the setting level
(eg, insufficient reimbursement for group therapy by insurance
companies), the participant and therapist level (eg, unknown motivation
for group therapy due to the established 1:1 patient-therapist ratio),
and the outcome measure level (eg, lack of standardized,
cross-culturally translated manuals).
While task-oriented circuit
training is scientifically well established, barriers to implementation
into routine care in Germany and Austria can be expected. In a next
step, research using knowledge translation methodology will focus on the
detailed evaluation of barriers and facilitators with the relevant
stakeholders.
Have your doctor check these out. Or does your doctor prefer not knowing about successfull stroke rehab elsewhere? That way extra work does not need to be done.
Stefan Hesse, MD; 1 * Henning Schmidt, Dipl-Ing; 2 Cordula Werner, MA 1 1 Klinik Berlin/Charité University Hospital, Department of Neurological Rehabilitation, Berlin, Germany; 2 Fraunhofer Institut–Institut für Produktionsanlagen und Konstruktionstechnik
(IPK) Berlin, Germany
Abstract—
The group at Klinik Berlin/Charite University Hospital in Berlin, Germany, began studies to promote motor recovery after stroke in the early 1990s. Following the intro-duction of treadmill training with partial body-weight support, the group designed an electromechanical gait trainer, GT I, based on movable foot plates that relieve therapist effort (e.g., when assisting the movement of the paretic limbs) and intensify patient gait training (GT). Preliminary results of a recent multicenter trial of 155 acute stroke patients showed that the GT I effectively promotes gait ability and competence in activities of daily living. The experimental group received 20 min of GT and 25 min of physiotherapy (PT) and the control group received 45 min of PT every day for 4 weeks. The laboratory’s next step was the Haptic Walker, a robotic walking simulator with freely programmable foot plates so that patients can, for example, additionally train for stair climbing and perturbations. The foot plates can be operated in full guidance or compliance control modes, thus reducing foot support according to the patient’s learning success. For the severely affected upper limb, the laboratory’s computerized arm trainer, called the Bi-Manu-Track, enables bilateral practice of forearm prona-tion/supination and wrist flexion/extension. Compared with electrical stimulation of the paretic wrist extensors, acute stroke patients with severe arm paresis (n = 44) had significantly more upper-limb muscle strength and control at the end of the 6-week intervention period and at follow-up. The laboratory’s most recent and cost-effective development, the Nudel-holz, is a purely mechanical device that bilaterally trains the shoulder, elbow, and wrist joints. It is intended for home therapy.
Key words:
arm rehabilitation, controlled trials, gait, hemi-paresis, locomotion, motor rehabilitation, physiotherapy, robot-assisted therapy, robotics, stroke.
INTRODUCTION
We at the neurorehabilitation research laboratory at Klinik Berlin/Charité University Hospital began work in motor rehabilitation of stroke patients in the early 1990s. Guided by the task-specific treatment concept, we successfully introduced treadmill training with partial body-weight support in the gait rehabilitation of chronic hemi-paretic subjects [1]. In daily practice, the therapist effort required to assist patients’ walking, e.g., when placing the paretic limbs, limits the intensity of therapy. Our next step was to develop the electromechanical gait trainer, GT I. On this machine, patients are secured with a harness and their feet placed on two driven foot plates whose movement simulates stance and swing. The robotic walking simulator, Haptic Walker, continues this concept. It is based on the principle of programmable foot plates that allows the training of arbitrary foot motions, such as walking on level ground and climbing up and down stairs, based on real foot motion data. The control modes range from position-controlled to force- and compliance-controlled motions during swing phase, and include simulation of perturbations. For the upper limb, we developed the Bi-Manu-Track to treat severely affected stroke subjects who have no volitional distal wrist and finger activity. The Bi-Manu-Track enables the bilateral practice of two distal movement cycles. It is a robotic device offering different position and compliance control modes for therapy. Our latest, most cost-effective development, the purely mechanical Nudelholz (“rolling pin”), is intended for home therapy. This article presents the devices and related clinical studies for the motor rehabilitation of these upper and lower limbs.
This is from Germany, but any objective look at stroke results anywhere in the world would consider them to be a complete failure. Yet there is always this happy talk about prevention and getting to the hospital fast so you can get tPA. Both of which have to be considered complete failures. http://www.alphagalileo.org/ViewItem.aspx?ItemId=147865&CultureCode=en
Stroke is one of the most common disorders in Germany, with more than
250,000 cases every year. The consequences for those affected are
dramatic: fewer than six in every 10 patients leave the hospital with a
positive prognosis after a stroke. The others will have disabilities
three months post-stroke or will have died. High-quality acute treatment
is therefore crucially important. In the current issue of Deutsches Ärzteblatt International (Dtsch
Arztebl Int 2014; 111: 759–65), the German Stroke Registers Study Group
(ADSR) documents the quality of treatment of patients with acute stroke
on the basis of case data from participating hospitals. The current
study reported by Silke Wiedmann and colleagues shows to what extent the
ADSR’s quality indicators were put into practice in 2012.
To this end, they investigated the disease course of more than
260,000 patients from 627 hospitals nationwide, which represents an
estimated 70% of all stroke cases in Germany. The study shows that in
many areas, stroke patients received very good treatment, and that in
the international comparison, a similar or even better quality is
achieved in Germany. In some areas, the targeted treatment quality is
not fully realized—for example, in the administration of anticoagulants
in atrial fibrillation, screening for dysphagia, or the provision of
information to patients or their relatives. The authors therefore
recommend implementing consistent standards throughout Germany.
I can't find the research listed but these researchers need to read research on the neuronal cascade of death. Stupidity rules. http://www.newsfix.ca/2013/11/22/death-in-hospital-after-stroke/
A study looks at the factors that influence death in the hospital after a stroke.
Treatment with clot-busting drugs such as tissue plasminogen activator
(tPA) is now accepted to be a good way of treating an acute stroke.
Nevertheless, some patients having this treatment still die in hospital.
Researchers at the University of Muenster, Germany, have been looking
at the factors which influence the outcome for patients having tPA
treatment for stroke.
They looked at 1,628 patients admitted with acute stroke in Germany
during 2000 and 2002. Of those who were treated with tPA, ten per cent
died while in hospital – with around two thirds of the deaths occurring
within seven days of admission. The factors affecting the risk of death
were older age and altered level of consciousness on admission. And the
researchers also noted that the more experience the hospital had in
using tPA, the less the risk of in-hospital death after treatment. The
researchers say that those who are most at risk of death, even after
clot-busting treatment for stroke, will need to be given extra attention
in hospital.